Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4383-4390

  Cos, Samuel ^a   Fernández, Rosario ^a   Güézmes, Andrés ^b   Sánchez Barcelo, Emilio J ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MELATONIN; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER INVASION; COLLAGEN DEGRADATION; HORMONE ACTION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; METASTASIS POTENTIAL; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; BASEMENT MEMBRANE; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL DIVISION; CHEMOTAXIS; COLLAGENASES; CULTURE MEDIA, CONDITIONED; ESTRADIOL; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASE 9; MELATONIN; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; VIMENTIN;

EID: 0032188888     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Blask, D. E. The pineal: an oncostatic gland? In: R. J. Reiter (ed.), The Pineal Gland, pp. 253-284. New York: Raven Press, 1984.
2. Blask, D. E., and Hill, S. M. Melatonin and cancer: basic and clinical aspects. In: A. Miles, D. R. S. Philbrick, and C. Thompson (eds.), Melatonin Clinical Perspectives, pp. 128-173. New York: Oxford University Press, 1988.
3. Sánchez-Barceló, E. J., Cos, S., and Mediavilla, M. D. Influence of pineal gland function on the initiation and growth of hormone-dependent breast tumors. Possible mechanisms. In: D. Gupta, A. Attanasio, and R. J. Reiter (eds.), The Pineal Gland and Cancer, pp. 221-232. Tübingen, Germany: Brain Research Promotion, 1988.
4. Sánchez-Barcelo, E. J., Mediavilla, M. D., and Cos, S. Effects of melatonin on experimental mammary cancer development. In: S. M. Webb, M. Puig-Domingo, M. Moller, and P. Pevet (eds.), Pineal Update: From Molecular Mechanisms to Clinical Implications, pp. 361-368. New York: PJD Publications Limited, 1997.
5. Blask, D. E., Hill, S. M., Pelletier, D. B., Anderson, J. M., and Lemus-Wilson, A. Melatonin: an anticancer hormone of the pineal gland. In: R. J. Reiter and S. F. Pang (eds.), Advances in Pineal Research, Vol. 3, pp. 259-263. London: John Libbey, 1989.
6. Maestroni, G. J. M. The immunoneuroendocrine role of melatonin. J. Pineal Res., 14: 1-10, 1993.
7. Poeggeler, B., Reiter, R. J., Tang, D. X., Chen, L. D., and Manchester, L. C. Melatonin, hydroxyl radical-mediated oxidative damage and aging: a hypothesis. J. Pineal Res., 14: 151-168, 1993.
8. Tan, D. X., Chen, L. D., Poeggeler, B., Manchester, L. C., and Reiter, R. J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr. J., 1: 57-60, 1993.
9. Blask, D. E., and Hill, S. M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural Transm., 21 (Suppl.): 433-449, 1986.
10. Cos, S., Blask, D. E., Lemus-Wilson, A., and Hill, A. B. Effects of melatonin on the cell cycle kinetics and "estrogen rescue" of MCF-7 human breast cancer cells in culture. J. Pineal Res., 10: 36-43, 1991.
11. Hill, S. M., Spriggs, L. L., Simon, M. A., Muraoka, H., and Blask, D. E. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett., 64: 249-256, 1992.
12. Cos, S., Fernández, F., and Sánchez-Barceló, E. J. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci., 58: 2447-2453, 1996.
13. Hill, S. M., and Blask, D. E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res., 48: 6121-6126, 1988.
14. Cos, S., and Sánchez-Barceló, E. J. Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. Cancer Lett., 85: 105-109, 1994.
15. Cos, S., and Sánchez-Barceló, E. J. Melatonin inhibition of MCF-7 human breast cancer cells growth: influence of cell proliferation rate. Cancer Lett., 93: 207-212, 1995.
16. Cos, S., Recio, J., and Sánchez-Barceló, E. J. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci., 58: 811-816, 1996.
17. Soule. H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. J. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1412, 1973.
18. Osborne, C. K., Hobbs, K., and Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45: 584-590, 1985.
19. Albini, A., Graf, J., Kitten, G. T., Kleinman, H. K., Martin, G. R., Veillette, A., and Lippman, M. E. 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane. Proc. Natl. Acad. Sci, USA. 83: 8182-8186, 1986.
20. Shafie, S., and Liotta, L. A. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett., 11: 81-87, 1980.
21. Gui, G. P. H., Puddefoot, J. R., Vinson, G. P., Wells, C. A., and Carpenter, R. Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br. J. Cancer, 75: 623-633, 1997.
22. Gui, G. P. H., Puddefoot, J. R., Vinson, G. P., Wells, C. A., and Carpenter, R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br. J. Surg., 82: 1192-1196, 1995.
23. Sommers, C. L., Byers, S. W., Thompson, E. W., Torri, J. A., and Gelmann, E. P. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat., 31: 325-335, 1994.
24. Thompson, E. W., Torri, J., Sabol, M., Sommers, C. L., Byers, S., Valverius, E. M., Martin, G. R., Lippman, M. E., Stampfer, M. R., and Dickson, R. B. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis, 12: 181-194, 1994.
25. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
26. Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., and Fidler, I. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett., 38: 137-147, 1987.
27. Repesh, L. A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis, 9: 192-208, 1989.
28. Nakajima, M., Welch, D. R., Belloni, P. N., and Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47: 4869-4876, 1987.
29. Nakajima, M., Lotan, D., Baig, M. M., Carralero, R. M., Wood, W. R., Hendrix, M. J. C., and Lotan, R. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res., 49: 1698-1706, 1989.
30. Molis, T. M., Walters, M. R., and Hill, S. M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int. J. Oncol., 3: 687-694, 1993.
31. Cos. S., and Blask, D. E. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res., 17: 25-32, 1994.
32. Molis, T. M., Spriggs, L. L., Jupiter, Y., and Hill, S. M. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J. Pineal Res., 18: 93-103, 1995.
33. Tamarkin, L., Danforth, D., Lichter, A., Demoss, E., Cohen, M., Chabner, B., and Lippman, M. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor-positive breast cancer. Science (Washington DC), 216: 1003-1005, 1982.
34. Lippman, M. E., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res., 36: 4610-4618, 1976.
35. Soule, H. D., and McGrath, C. M. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett., 10: 177-189, 1980.
36. Thompson, E. W., Reich, R., Shima, T. B., Albini, A., Graf, J., Martin, G. R., Dickson, R. B., and Lippman, M. E. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res., 48: 6764-6768, 1988.
37. Sapino, A., Pietribiasi, F., Bussolali, G., and Marchisio, P. C. Estrogen-and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. Cancer Res., 46: 2526-2531, 1986.
38. Millon, R., Nicora, F., Muller, D., Eber, M., Klein-Soyer, C., and Abecassis, J. Modulation of human breast cancer cell adhesion by estrogens and antiestrogens. Clin. Exp. Metastasis, 7: 405-415, 1989.
39. Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., and Trevor, K. T. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am. J. Pathol., 150: 483-495, 1997.
40. Yagasaki, R., Noguchi, M., Minami, M., and Earashi, M. Clinical significance of E-cadherin and vimentin co-expression in breast cancer. Int. J. Oncol., 9: 755-761, 1996.
41. Zutter, M. M., Mazoujian, G., and Santoro, S. A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol., 137: 863-870, 1990.
42. Crespo, D., Fernández-Viadero, C., Verduga, R., Ovejero, V., and Cos, S. Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J. Pineal Res., 16: 215-222, 1994.
43. Osborne, C. K. Effects of estrogens and antiestrogens on human breast cancer cell proliferation: in vitro studies in tissue culture and in vivo studies in athymic mice. In: V. P. Hollander (ed.), Hormonally Responsive Tumors, pp. 93-113. Orlando, FL: Academic Press, 1985.
44. Das Gupta, T. K., and Terz, J. Influence of pineal gland on the growth and spread of melanoma in the hamster. Cancer Res., 27: 1306-1311, 1967.
45. Lissoni, P., Barni, S., Meregalli, S., Fossati, V., Cazzaniga, M., Esposti, D., and Tancini, G. Modulation of cancer endocrine therapy by melatonin: a Phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br. J. Cancer, 71: 854-856, 1995.